Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$28.03 - $45.8 $873,274 - $1.43 Million
-31,155 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$29.24 - $44.06 $63,012 - $94,949
2,155 Added 7.43%
31,155 $1.29 Million
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $602,461 - $943,988
-15,322 Reduced 34.57%
29,000 $1.24 Million
Q3 2021

Nov 15, 2021

SELL
$44.0 - $65.8 $296,296 - $443,097
-6,734 Reduced 13.19%
44,322 $2.44 Million
Q2 2021

Aug 16, 2021

SELL
$44.66 - $63.06 $570,978 - $806,222
-12,785 Reduced 20.03%
51,056 $2.44 Million
Q1 2021

May 17, 2021

BUY
$46.31 - $62.7 $2.96 Million - $4 Million
63,841 New
63,841 $3.23 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.